Dasatinib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Dasatinib
May 15, 2024, 14:18 |
Blog
Talha Badar: Choice of frontline TKI for CML-CP
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on Twitter/X:…
Apr 20, 2024, 07:03 |
Drugs
Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Feb 28, 2024, 12:20 |
Blog
Aaron Goodman: Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen
Aaron Goodman recently shared a post on X/Twitter: "Saw dasatinib-induced hyperthyroidism in one of my patients…
Jun 16, 2023, 19:38 |
Drugs
Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP
In a post by Hagop Kantarjian on Twitter, it says, "Dasatinib 50 mg daily is…
All:
5
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube